Understanding Menopause: A Complete Guide
What Every Woman Should Know
Published by Life and Mind Coaching Academy | May 2026
Menopause is one of the most significant biological transitions in a woman's life, yet for generations it has been surrounded by silence, misinformation, and misunderstanding. Too many women have navigated this stage of life without adequate knowledge, support, or language to describe what they are experiencing.
That is changing. Conversations about menopause are becoming more open, more informed, and more compassionate — and rightly so. Understanding what menopause is, what it does to the body and mind, and how it can be managed, is not a niche concern. It is a matter of healthcare, wellbeing, and dignity.
This guide explores the science behind menopause, its stages and symptoms, its effects on physical and mental health, and the evidence-based approaches available to support women through this transition and beyond.
What Is Menopause?
Menopause is defined as the point at which a woman has not had a menstrual period for 12 consecutive months, marking the end of her reproductive years. It occurs as the ovaries gradually reduce and eventually cease their production of the hormones oestrogen and progesterone (British Menopause Society, 2023).
In the UK, the average age of natural menopause is 51, though it can occur anywhere between the ages of 45 and 55. Menopause before the age of 45 is referred to as early menopause, and before the age of 40 as premature ovarian insufficiency (POI), which affects approximately 1 in 100 women (NHS, 2022).
Menopause can also be induced surgically — through removal of the ovaries (oophorectomy) — or as a result of certain medical treatments such as chemotherapy or radiotherapy. In these cases, menopause is often more abrupt and symptoms may be more intense.
The Three Stages of Menopause
Menopause is not a single moment — it is a process that unfolds across three distinct stages.
Perimenopause
Perimenopause is the transitional phase leading up to menopause, during which hormone levels begin to fluctuate and decline. It can begin anywhere from two to ten years before the final menstrual period, typically starting in a woman's mid-to-late forties, though it can begin earlier (Santoro et al., 2021).
During perimenopause, periods may become irregular — closer together or further apart, lighter or heavier than usual. Many of the most commonly associated symptoms of menopause — including hot flushes, sleep disturbances, and mood changes — begin during this stage. Because periods have not yet stopped, many women do not realise they are already in perimenopause.
Menopause
Menopause itself is confirmed retrospectively: a woman is considered to have reached menopause after 12 consecutive months without a period. At this point, the ovaries have significantly reduced their hormone production, and the body is adjusting to its new hormonal baseline.
Postmenopause
Postmenopause refers to the years following menopause. While many symptoms ease over time, some — particularly those related to genitourinary health and bone density — can persist or develop further in the postmenopausal years. Long-term health considerations become increasingly important during this stage (Stuenkel et al., 2015).
The Science Behind Menopause
To understand menopause is to understand the role of hormones — particularly oestrogen.
Oestrogen is produced primarily by the ovaries and plays a far broader role in the body than reproduction alone. It is involved in regulating body temperature, maintaining bone density, supporting cardiovascular health, influencing mood and cognition, and maintaining the health of the vaginal and urinary tissues (Burger et al., 2002).
As the ovaries age, the number of follicles — the structures that produce oestrogen and release eggs — declines. This leads to increasingly erratic hormone levels during perimenopause, before oestrogen levels fall significantly and stabilise at a lower level after menopause.
Progesterone, produced after ovulation, also declines during the menopausal transition. The relative imbalance between oestrogen and progesterone during perimenopause contributes to many of the symptoms women experience during this time.
Follicle-stimulating hormone (FSH), produced by the pituitary gland to stimulate the ovaries, rises during the menopausal transition as the body attempts to stimulate diminishing ovarian activity. Elevated FSH levels alongside symptoms and menstrual changes are indicators used in clinical assessment, though diagnosis in women over 45 is typically made on clinical grounds rather than blood testing alone (NICE, 2019).
Symptoms of Menopause
Menopause affects every woman differently. Some experience minimal disruption; others find symptoms profoundly affect their quality of life. Research suggests that around 75% of women experience vasomotor symptoms such as hot flushes, while up to 25% describe symptoms as severely impacting their daily functioning (Avis et al., 2015).
Vasomotor Symptoms
Hot flushes are the hallmark symptom of menopause, experienced by the majority of women during the transition. They are characterised by a sudden sensation of heat, typically beginning in the chest and spreading to the neck and face, often accompanied by sweating, flushing, and a rapid heartbeat. They can last from a few seconds to several minutes and may occur multiple times throughout the day and night.
Night sweats are the nocturnal equivalent of hot flushes and are a leading cause of sleep disruption during menopause.
Sleep Disturbances
Poor sleep is one of the most frequently reported and most debilitating aspects of the menopausal transition. Beyond night sweats, falling oestrogen levels affect the regulation of sleep architecture, reducing the proportion of restorative deep sleep and making wakefulness during the night more common (Baker et al., 2018).
Psychological and Cognitive Symptoms
Mood changes, anxiety, low mood, and irritability are common during perimenopause and menopause. These are not simply emotional responses to change — they have a physiological basis. Oestrogen influences the production and regulation of serotonin and dopamine, both of which play central roles in mood regulation (Lokuge et al., 2011).
Brain fog — difficulties with memory, concentration, and word retrieval — is reported by a significant proportion of women during the menopausal transition. While often perceived as alarming, research indicates that cognitive function typically stabilises and improves following the menopausal transition (Weber et al., 2014).
It is important to note that women with a history of depression or anxiety may experience heightened psychological symptoms during perimenopause. Healthcare professionals should be alert to this and ensure appropriate support is in place.
Genitourinary Symptoms
Declining oestrogen leads to thinning and drying of the vaginal tissues — a condition now termed Genitourinary Syndrome of Menopause (GSM). Symptoms include vaginal dryness, discomfort during intercourse, increased urinary frequency, and recurrent urinary tract infections. Unlike vasomotor symptoms, which often improve with time, GSM tends to worsen progressively without treatment (Portman & Gass, 2014).
Musculoskeletal Symptoms
Joint pain, stiffness, and muscle aches are frequently reported during the menopausal transition, though they are less commonly discussed. Oestrogen has anti-inflammatory properties, and its decline may contribute to increased joint discomfort (Szoeke et al., 2008).
Other Symptoms
Additional symptoms associated with menopause include changes to skin and hair (increased dryness, thinning), headaches, heart palpitations, reduced libido, and changes in body composition, including an increase in abdominal fat.
Long-Term Health Implications
Beyond the symptoms of the transitional period, reduced oestrogen levels have significant implications for long-term health.
Bone Health
Oestrogen plays a critical role in maintaining bone density. Following menopause, bone loss accelerates significantly — women can lose up to 20% of their bone density in the five to seven years following menopause (National Osteoporosis Foundation, 2021). This substantially increases the risk of osteoporosis and fragility fractures, particularly of the hip, spine, and wrist.
Weight-bearing exercise, adequate calcium and vitamin D intake, and — where appropriate — hormone replacement therapy are all important strategies for protecting bone health in postmenopausal women.
Cardiovascular Health
Prior to menopause, oestrogen offers a degree of cardiovascular protection — it supports healthy cholesterol levels, maintains arterial flexibility, and has anti-inflammatory effects. After menopause, cardiovascular risk increases, and heart disease becomes the leading cause of death in postmenopausal women (Muka et al., 2016).
Lifestyle factors including regular physical activity, a heart-healthy diet, not smoking, and maintaining a healthy weight are particularly important in the postmenopausal years.
Management and Treatment Options
There is no single correct approach to managing menopause. Treatment decisions are deeply personal and should be made collaboratively between a woman and her healthcare provider, taking into account her symptoms, medical history, preferences, and values.
Hormone Replacement Therapy (HRT)
HRT remains the most effective treatment for menopausal symptoms, particularly vasomotor symptoms (NICE, 2019). Modern HRT typically involves oestrogen — delivered via patches, gel, spray, or tablets — combined with progesterone for women who have a uterus, to protect the uterine lining.
The risks associated with HRT have been significantly re-evaluated since earlier studies raised concerns. Current evidence from the British Menopause Society indicates that for most healthy women under 60 who begin HRT within ten years of menopause, the benefits outweigh the risks (Hamoda et al., 2020). Individual risk assessment is essential, and decisions should be made on a case-by-case basis.
Non-Hormonal Medications
For women who are unable or prefer not to take HRT, several non-hormonal options exist. These include certain antidepressants (such as SSRIs and SNRIs), clonidine, and gabapentin, which have been shown to reduce vasomotor symptoms in clinical trials (NICE, 2019).
Lifestyle Approaches
Lifestyle modifications can make a meaningful difference to the experience of menopause:
- Regular physical activity, including both aerobic exercise and strength training, supports mood, sleep, bone density, and cardiovascular health.
- A balanced diet rich in calcium, vitamin D, phytoestrogens (found in soy, flaxseed, and legumes), and omega-3 fatty acids supports multiple aspects of menopausal health.
- Reducing alcohol and caffeine intake may help reduce the frequency and severity of hot flushes.
- Maintaining a healthy weight reduces vasomotor symptom burden and cardiovascular risk.
- Mindfulness-based stress reduction (MBSR) and cognitive behavioural therapy (CBT) have demonstrated effectiveness in reducing the psychological impact of menopause and improving sleep quality (Ayers et al., 2012).
Vaginal Oestrogen
For genitourinary symptoms specifically, localised vaginal oestrogen — available as creams, pessaries, or rings — is highly effective, has minimal systemic absorption, and can be used long term by most women, including those who are not suitable for systemic HRT (Portman & Gass, 2014).
Menopause in the Workplace
One in three women in the UK workforce is over the age of 50, and yet menopause remains an underacknowledged occupational health issue. Symptoms such as fatigue, brain fog, and anxiety can significantly affect concentration, confidence, and performance at work.
Research by the Chartered Institute of Personnel and Development (CIPD, 2019) found that three in five women experiencing menopause symptoms reported a negative impact on their work, and many felt unable to speak openly with their employers about their experiences.
Employers have a duty of care and may be required under the Equality Act 2010 to make reasonable adjustments for employees experiencing significant menopausal symptoms. A growing number of organisations are developing menopause policies and training, and healthcare professionals and coaches are increasingly called upon to support women in navigating this aspect of their lives.
Seeking Support
No woman should navigate menopause alone or in silence. If you are experiencing symptoms that are affecting your quality of life, please speak to your GP. You are entitled to a thorough assessment, access to evidence-based treatments, and support that is tailored to your individual needs.
Useful resources include:
- The British Menopause Society — bms.org.uk
- Menopause Matters — menopausematters.co.uk
- The Menopause Charity — themenopausecharity.org
- NHS Menopause information — nhs.uk/conditions/menopause
Final Thoughts
Menopause is not an illness. It is not the end of vitality, identity, or possibility. It is a natural biological transition — one that deserves to be understood, discussed openly, and navigated with proper support.
Knowledge is the foundation of that support. When women understand what is happening in their bodies, they are better equipped to seek help, make informed decisions, and approach this stage of life with confidence rather than confusion or fear.
At Life and Mind Coaching Academy, we believe that education is empowerment. Understanding menopause is part of understanding yourself — and that understanding has the power to change everything.
References
Avis, N. E., Crawford, S. L., Greendale, G., Bromberger, J. T., Everson-Rose, S. A., Gold, E. B., Hess, R., Joffe, H., Kravitz, H. M., Tepper, P. G., & Thurston, R. C. (2015). Duration of menopausal vasomotor symptoms over the menopause transition. JAMA Internal Medicine, 175(4), 531–539.
Ayers, B., Smith, M., Hellier, J., Mann, E., & Hunter, M. S. (2012). Effectiveness of group and self-help cognitive behavior therapy in reducing problematic menopausal hot flushes and night sweats. Menopause, 19(7), 749–759.
Baker, F. C., de Zambotti, M., Colrain, I. M., & Bei, B. (2018). Sleep problems during the menopausal transition: Prevalence, impact, and management challenges. Nature and Science of Sleep, 10, 73–95.
British Menopause Society. (2023). Menopause: An overview. https://thebms.org.uk
Burger, H. G., Dudley, E. C., Robertson, D. M., & Dennerstein, L. (2002). Hormonal changes in the menopause transition. Recent Progress in Hormone Research, 57, 257–275.
Chartered Institute of Personnel and Development. (2019). Menopause in the workplace: Employee experiences in the UK. CIPD.
Hamoda, H., Mukherjee, A., Morris, E., Baldeweg, S. E., Jayasena, C. N., Briggs, P., & Moger, S. (2020). Joint position statement by the British Menopause Society, Royal College of Obstetricians and Gynaecologists and Society for Endocrinology on best practice recommendations for the care of women experiencing the menopause. Post Reproductive Health, 26(3), 123–130.
Lokuge, S., Frey, B. N., Foster, J. A., Soares, C. N., & Steiner, M. (2011). Depression in women: Windows of vulnerability and new insights into the link between oestrogen and serotonin. Journal of Clinical Psychiatry, 72(11), e1563–e1569.
Muka, T., Oliver-Williams, C., Kunutsor, S., Laven, J. S. E., Fauser, B. C. J. M., Chowdhury, R., Kavousi, M., & Franco, O. H. (2016). Association of age at onset of menopause and time since onset of menopause with cardiovascular outcomes. JAMA Cardiology, 1(7), 767–776.
National Institute for Health and Care Excellence. (2019). Menopause: Diagnosis and management (NICE guideline NG23). https://www.nice.org.uk/guidance/ng23
National Osteoporosis Foundation. (2021). Bone health basics. https://www.nof.org
Portman, D. J., & Gass, M. L. S. (2014). Genitourinary syndrome of menopause: New terminology for vulvovaginal atrophy from the International Society for the Study of Women's Sexual Health and the North American Menopause Society. Menopause, 21(10), 1063–1068.
Santoro, N., Roeca, C., Peters, B. A., & Neal-Perry, G. (2021). The menopause transition: Signs, symptoms, and management options. Journal of Clinical Endocrinology and Metabolism, 106(1), 1–15.
Stuenkel, C. A., Davis, S. R., Gompel, A., Lumsden, M. A., Murad, M. H., Pinkerton, J. V., & Santen, R. J. (2015). Treatment of symptoms of the menopause: An Endocrine Society clinical practice guideline. Journal of Clinical Endocrinology and Metabolism, 100(11), 3975–4011.
Szoeke, C. E. I., Cicuttini, F. M., Guthrie, J. R., & Dennerstein, L. (2008). The relationship of reports of aches and joint pains to the menopausal transition. Climacteric, 11(1), 55–62.
Weber, M. T., Maki, P. M., & McDermott, M. P. (2014). Cognition and mood in perimenopause: A systematic review and meta-analysis. Journal of Steroid Biochemistry and Molecular Biology, 142, 90–98.
Life and Mind Coaching Academy | www.lifeandmindcoaching.com | Your journey. Your way. Always.